Rynazma Syrup 60 ml

Rynazma Syrup belongs to the class of medications known as bronchodilators. It is used to prevent and treat symptoms of asthma and chronic obstructive pulmonary disease (COPD). Asthma is a chronic (long-term) respiratory condition in which airways narrow, swell, and produce extra mucus, leading to difficulty in breathing. COPD is a group of lung diseases that includes emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of the bronchial tubes).

Rynazma Syrup contains Doxofylline. It works by relaxing the muscles of the airways and lungs, making it easier to breathe. It inhibits an enzyme called phosphodiesterase, which increases the levels of a chemical (cAMP) that helps open up the airways. This reduces symptoms like wheezing, coughing, and shortness of breath in asthma and COPD.

The dose and duration of treatment with Rynazma Syrup can be determined by the doctor based on your medical condition. Some people may experience headaches, nausea, vomiting, stomach pain, irritability, insomnia (difficulty in falling or staying asleep) or a fast heart rate. Most of these side effects of Rynazma Syrup do not require medical attention and typically resolve on their own over time. However, if the side effects persist or worsen, please consult your doctor.

Rynazma Syrup is contraindicated in acute myocardial infarction, low blood pressure (hypotension), lactating women and patients allergic to Rynazma Syrup. Let your doctor know if you are pregnant or planning for pregnancy, before taking Rynazma Syrup. Rynazma Syrup should be used with caution in congestive heart failure patients as these patients have slow drug clearance, leading to high blood levels even after stopping treatment with Rynazma Syrup. Rynazma Syrup is not recommended for children below 6 years of age, as the safety and effectiveness have not been established.

Rynazma Syrup is used for the treatment of respiratory conditions that cause breathing difficulties. The detailed uses of Rynazma Syrup are as follows:

• Treats asthma: Helps relieve symptoms such as wheezing, breathlessness, and chest tightness by relaxing airway muscles.
• Manages chronic obstructive pulmonary disease (COPD): Improves airflow and reduces flare-ups in patients with chronic bronchitis or emphysema.

• Rynazma Syrup can be taken with or without food, as advised by the doctor.
• Follow your doctor's instructions on the dosage and timing of this medication.
• Swallow Rynazma Syrup as a whole with a glass of water.
• Do not crush, break, or chew it.

Rynazma Syrup is a bronchodilator and also possesses antitussive (cough suppressant) properties that are used to treat symptoms of asthma and chronic obstructive pulmonary disease (COPD). Rynazma Syrup works by relaxing muscles and widening the airways in the lungs, particularly in patients with asthma and COPD. Additionally, Rynazma Syrup helps suppress coughs and makes breathing easier by opening airways. Thus, it prevents an asthma attack, and an individual can exercise freely if it is taken before exercise or before expected exposure to irritants such as pollen, house dust, cigarette smoke and pets.

If you are allergic to Rynazma Syrup or any other medicines, please tell your doctor. You are recommended to avoid taking Rynazma Syrup with chocolate and caffeinated foods, such as cocoa beans or tea leaves, as they may increase the risk of severe side effects. Rynazma Syrup is contraindicated in breastfeeding mothers. If you are pregnant or planning for pregnancy, please consult a doctor before using Rynazma Syrup. Do not take Rynazma Syrup if you have low blood pressure or have had a heart attack. Rynazma Syrup should be used with caution in congestive heart failure patients, as these patients have slow drug clearance, leading to high blood levels even after stopping treatment with Rynazma Syrup. If you have low blood pressure, congestive heart failure, hypoxemia (low oxygen levels in the blood), hyperthyroidism (overactive thyroid), pulmonary heart diseases, stomach ulcer, kidney, liver or heart diseases, inform your doctor before taking Rynazma Syrup. Rynazma Syrup is not recommended for children under 6 years of age, as its safety and efficacy have not been fully established.